All news

500,000 option-exercise shares are part of an officer's planned sale at Pacific Biosciences (PACB).

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Pacific Biosciences officer Jim Gibson plans to sell 661,815 common shares, valued at approximately

Read original source

PACB company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.